about
A comparison of effects measured with isotonic and isometric recording: II. Concentration-effect curves for physiological antagonistsThe action of 2-O-Methyltyrosine-oxytocin on the rat and rabbit uterus: effect of some experimental conditions on change from agonism to antagonism.Down-regulation of heat shock protein 70 improves arsenic trioxide and 17-DMAG effects on constitutive signal transducer and activator of transcription 3 activityAgonist and antagonist properties of buprenorphine, a new antinociceptive agent.Oligomerization of G protein-coupled receptors: past, present, and future.Antagonism of the effect of isoprenaline on heart rate by pilocarpine.Mechanism-based mathematical modeling of combined gemcitabine and birinapant in pancreatic cancer cells.Interactions of everolimus and sorafenib in pancreatic cancer cells.Interactions of everolimus and sorafenib in whole blood lymphocyte proliferation.Synergism between arsenic trioxide and heat shock protein 90 inhibitors on signal transducer and activator of transcription protein 3 activity--pharmacodynamic drug-drug interaction modelingTargeting 11q23 positive acute leukemia cells with high molecular weight-melanoma associated antigen-specific monoclonal antibodiesPharmacodynamic Modeling of Cell Cycle Effects for Gemcitabine and Trabectedin Combinations in Pancreatic Cancer CellsPK/PD studies on non-selective PDE inhibitors in rats using cAMP as a marker of pharmacological response.Assessment of non-linear combination effect terms for drug-drug interactions.Sequential Exposure of Bortezomib and Vorinostat is Synergistic in Multiple Myeloma Cells.In vivo receptor binding of the opiate partial agonist, buprenorphine, correlated with its agonistic and antagonistic actionsA COMPARISON OF THE EFFECTS OF SOME ETHONIUM IONS AND THEIR STRUCTURAL ANALOGUES ON NEUROMUSCULAR TRANSMISSION IN THE CAT.Fourth gaddum memorial lecture, school of pharmacy, university of london, january 1973.A general pharmacodynamic interaction model identifies perpetrators and victims in drug interactions.Target mediated drug disposition with drug-drug interaction, Part II: competitive and uncompetitive cases.Temporal Effects of Combined Birinapant and Paclitaxel on Pancreatic Cancer Cells Investigated via Large-scale, Ion-Current-Based Quantitative Proteomics (IonStar).
P2860
Q28345470-92148F0A-A229-4B50-99B8-7BBD63514653Q35011674-3DC6FED3-7A6A-4527-AB9B-0D8AF62F1D85Q35154641-A8DB05E3-2225-4684-9B3D-2897F485D01DQ35176503-CA22E62B-4568-450B-B28B-1AA3A935133CQ35546811-691D0E3A-C5B5-49C9-A4F2-288AFA8C485FQ35601396-F5934374-F722-4A0A-ABE7-EF00215A9D8AQ36094941-F290D0E8-158E-45EA-87CD-2BACDC3296DEQ36502419-93380913-7D2D-4464-851C-94A616BF04A3Q37052630-8A21C58B-FC17-40F2-B14D-14E7F595C47CQ37275674-199076D4-7093-47DD-95AF-10135D9EB396Q37340948-7C9ABE32-533A-4B82-82DD-41FE7EA516A3Q37413497-B86DBF9A-C735-48B2-9136-6CEEFBD9F22AQ38653998-499CC440-022C-4D6F-AE57-237C13BAFF4CQ38957295-D2769DCA-5C50-49A2-835D-F24F1C5B86DEQ39013265-F2049E9E-8BFF-4C3B-8E13-FA6D707D8EB8Q39930922-E7368F3E-480E-48E9-8622-F3B6BD75DCC0Q41408313-9D4EEF24-2B64-414E-A239-7ED3CCC4F75CQ43002524-0A1F22FE-1066-4C19-8CB1-EB9389DBFC61Q47129748-9869FAB5-04B4-4B98-A612-9B6A2A6CCE5BQ48015244-89BD601B-BCB0-45DD-AA71-50978B0BCF3FQ49874345-98A554B7-DD13-4AE5-A2AD-4C6EB5922318
P2860
description
1957 nî lūn-bûn
@nan
1957 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1957 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1957年の論文
@ja
1957年論文
@yue
1957年論文
@zh-hant
1957年論文
@zh-hk
1957年論文
@zh-mo
1957年論文
@zh-tw
1957年论文
@wuu
name
Affinity, intrinsic activity and drug interactions.
@ast
Affinity, intrinsic activity and drug interactions.
@en
Affinity, intrinsic activity and drug interactions.
@nl
type
label
Affinity, intrinsic activity and drug interactions.
@ast
Affinity, intrinsic activity and drug interactions.
@en
Affinity, intrinsic activity and drug interactions.
@nl
prefLabel
Affinity, intrinsic activity and drug interactions.
@ast
Affinity, intrinsic activity and drug interactions.
@en
Affinity, intrinsic activity and drug interactions.
@nl
P2093
P1476
Affinity, intrinsic activity and drug interactions.
@en
P2093
SIMONIS AM
VAN ROSSUM JM
P304
P577
1957-06-01T00:00:00Z